How to Read a Peptide COA: HPLC, LC-MS, Endotoxin and Lot Traceability
A peptide Certificate of Analysis is a lot-specific analytical record—not a universal safety certificate. This guide explains what each common result measures and what it cannot establish.
The 60-second COA verification check
- Confirm the supplier, product and presentation.
- Match the lot number on the vial and report.
- Identify the laboratory and unique report number.
- Check sample receipt, testing and issue dates.
- Find the methods, results, units and reporting limits.
- Confirm page count, authorization and revision status.
- Retain the complete report, chromatograms and spectra—not a cropped badge.
What each analytical result answers
| Attribute | Common method | Question answered | Important limitation |
|---|---|---|---|
| Identity | LC-MS; stronger with MS/MS or peptide mapping | Is detected mass or fragmentation consistent with the expected peptide? | An intact-mass match may not distinguish every sequence, isomer or modification. |
| Chromatographic purity | RP-HPLC or UPLC | What proportion of integrated detectable area belongs to the assigned main peak? | Method-dependent and not equivalent to peptide content per vial. |
| Quantitative content | Calibrated HPLC, amino-acid analysis or validated mass-balance approach | How much peptide is present in the tested unit? | Requires suitable standards, calibration and a defined method. |
| Endotoxin | LAL or recombinant bacterial-endotoxin test | What endotoxin activity was detected under the reported conditions? | Does not establish sterility. |
| Formulation | Targeted assay or disclosed manufacturing record | Which excipients, counterions or other components are present? | Total dry mass is not automatically pure peptide mass. |
| Lot traceability | Label, report and chain-of-custody records | Can the tested sample be tied to the supplied lot? | Documentation supports traceability; it is not chemical testing. |
How to interpret HPLC purity
Reversed-phase HPLC separates sample components according to their chromatographic behavior. A common area-normalized result is calculated as the assigned main-peak area divided by total integrated relevant peak area, multiplied by 100.
That percentage is a relative chromatographic result under the stated column, gradient, detector wavelength, sample preparation and integration rules. It is not automatically:
- The amount of peptide in the vial
- Proof of molecular identity
- A complete mass balance
- Proof that every impurity was detected
- Proof that two co-eluting substances were separated
Review the chromatogram, main-peak assignment, method summary and integration. Detector response, co-elution and method design influence the result. Independent analytical characterization commonly uses chromatography for relative purity and mass spectrometry for identity rather than treating one method as both.
How to interpret LC-MS identity
LC-MS couples chromatographic separation with mass detection. A report may show several charge-state peaks and a deconvoluted molecular mass. Compare the observed result with the theoretical mass, stated chemical form and laboratory tolerance.
A matching intact mass supports identity, but it may not fully distinguish sequence isomers, positional modifications or closely related species. Tandem MS fragmentation, peptide mapping or another orthogonal method can provide stronger sequence-level evidence. Identity, purity and quantitative strength remain separate attributes.
HPLC purity is not measured peptide content
A vial reported as “99% HPLC purity” is not thereby proven to contain 99% of its nominal fill. A nominal 10 mg vial with a 99% chromatographic main peak still requires a calibrated quantitative assay to establish peptide content. Water, counterions, residual solvents and disclosed excipients can contribute to dry mass without being peptide content.
A strong report therefore distinguishes chromatographic purity from measured content rather than using one percentage to represent both.
How to interpret bacterial endotoxin results
Bacterial endotoxin tests detect or quantify endotoxin activity associated with Gram-negative bacteria. A useful report identifies the method type, sample preparation, result and unit, detection or reporting limit, and the applicable controls.
“Not detected” means below the method’s stated reporting capability under the tested conditions. It does not mean absolute zero. Most importantly, an endotoxin result is not a sterility test. Microbiological sterility and bacterial endotoxin are different quality attributes.
Verify lot traceability
The lot identifier should connect the physical vial label, order or receiving record, supplier product record, complete laboratory report, formulation or size distinction, and the laboratory’s internal inventory record. Retain the complete PDF rather than a cropped screenshot.
If a laboratory cites ISO/IEC 17025 accreditation, verify that the accreditation is current and review its stated scope. A logo alone does not establish that every method or individual result falls within the accredited scope.
Common COA red flags
- No lot, report ID or issue date
- A lot number that does not match the vial
- Only a cropped image rather than the complete report
- The same report reused across unexplained lots or formulations
- A purity percentage without a chromatogram or method
- A mass result presented as proof of quantity
- An HPLC result presented as proof of molecular identity
- “Zero endotoxin” without a reporting limit
- “Sterile” inferred only from an endotoxin result
- No disclosure of known excipients or formulation differences
An illustrative interpretation
Example report: nominal fill 20 mg; HPLC main-peak purity 99.5%; LC-MS mass consistent with the expected peptide; quantitative content 21.2 mg per vial; endotoxin below 0.05 EU/mL under the reported method.
These are four separate conclusions. HPLC describes the chromatographic profile, LC-MS supports identity, the quantitative assay estimates content, and the endotoxin method reports a result below its stated limit. No single result establishes all attributes, and the endotoxin result does not establish sterility.
Frequently asked questions
Does ≥99% HPLC purity mean a 10 mg vial contains 9.9 mg?
No. It describes relative chromatographic area, not peptide mass per vial.
Can mass spectrometry alone prove peptide identity?
An intact-mass match supports identity, while MS/MS fragmentation, peptide mapping or another orthogonal method can provide stronger sequence confirmation.
What does “endotoxin not detected” mean?
The result was below the stated reporting limit under the tested conditions—not that the absolute amount was zero.
Does an endotoxin pass mean the sample is sterile?
No. Sterility and bacterial endotoxin are separate quality attributes.
Is a third-party COA automatically reliable?
Independence is useful, but the report still needs a matching lot, identifiable laboratory, suitable methods, complete data and clear limits.
Standards and primary references
- USP: Reference Standards to Support Quality of Synthetic Peptide Therapeutics
- FDA: Synthetic Peptides Guidance for Industry
- ICH Q6A: Specifications and Analytical Procedures
- USP <85> Bacterial Endotoxins Test
- FDA: Pyrogen and Endotoxins Testing
- ISO/IEC 17025:2017
- NIST: Metrological Traceability